1. Characteristics and Cost of Unscheduled Hospitalizations in Patients Treated with New Oral Anticancer Drugs in Germany: Evidence from the Randomized AMBORA Trial
    Pauline Dürr et al, 2022, Journal of Clinical Medicine CrossRef
  2. Development and Utilization of Drug Lifecycle Data in the United States, Japan, and Europe
    Hee-Soo Yang et al, 2023, Journal of Health Informatics and Statistics CrossRef
  3. Racial Disparities in Breast Cancer Treatments and Adverse Events in the SEER-Medicare Data
    Robert Wieder et al, 2023, Cancers CrossRef
  4. Associations of readiness for hospital discharge with symptoms and non-routine utilization of post-discharge services among cancer patients receiving oral chemotherapy at home: A prospective study
    Yongfeng Chen et al, 2023, Journal of Oncology Pharmacy Practice CrossRef
  5. Associations of financial toxicity with symptoms and unplanned healthcare utilization among cancer patients taking oral chemotherapy at home: a prospective observational study
    Yongfeng Chen et al, 2023, BMC Cancer CrossRef
  6. A Risk-Factor Model for Antineoplastic Drug-Induced Serious Adverse Events in Cancer Inpatients: A Retrospective Study Based on the Global Trigger Tool and Machine Learning
    Ni Zhang et al, 2022, Frontiers in Pharmacology CrossRef